From one billionaire investor to another: NantPharm raises $125 million

Blackstone, the New York-based investment firm with $190 billion under management, has put $125 million as a minority investor into the biologics and pharmaceutical manufacturing unit of Nantworks - NantPharm - established in September 2011 by serial entrepreneur and billionaire philanthropist Patrick Soon-Shiong. The NantPharm unit is principally involved in pharmaceutical development and manufacturing.